Earkart

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE1A8F01035
  • NSEID:
  • BSEID: 544549
INR
125.00
0.00 (0.00%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 17000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

17.0 k (214.81%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

21.95%

Held by 0 DIIs

Promoter

57.34%

When is the next results date for Earkart Limited?

27-May-2026

The next results date for Earkart Limited is 29 May 2026.

The next results date for Earkart Limited is scheduled for 29 May 2026.

View full answer

Why is Earkart Limited falling/rising?

03-Jun-2026

As of 02-Jun, Earkart Limited's stock price is Rs. 125.00, up 5.04%, driven by strong sector performance and increased investor interest. However, it has faced significant volatility and recent declines, indicating that the rise may be a short-term correction rather than a reversal of its overall downward trend.

As of 02-Jun, Earkart Limited's stock price is currently at Rs. 125.00, reflecting an increase of Rs. 6.00 or 5.04%. This rise in stock price can be attributed to several factors observed today. Notably, the stock has outperformed its sector by 5.63%, indicating a relatively strong performance compared to its peers. Additionally, the stock reached an intraday high of Rs. 125, showcasing a recovery from its earlier low of Rs. 104.35, which marked a significant decline of 12.31%.<BR><BR>Despite the positive movement today, the stock has experienced considerable volatility, with an intraday volatility of 9%. This high volatility suggests that while the stock is currently rising, it has also faced significant fluctuations throughout the trading day. Furthermore, there has been a notable increase in investor participation, with delivery volume rising by 257.14% against the 5-day average, indicating growing interest among investors.<BR><BR>However, it is important to consider that Earkart Limited has been trading below its moving averages across various time frames, which may indicate underlying weakness in the stock's performance over a longer period. Additionally, the stock has experienced a decline of 10.62% over the past week and 18.83% over the past month, suggesting that the recent rise may be a short-term correction rather than a reversal of the overall downward trend.<BR><BR>In summary, while Earkart Limited's stock is currently rising due to strong sector performance and increased investor interest, it is essential to recognize the broader context of its recent declines and volatility.

View full answer

Which are the latest news on Earkart?

03-Jun-2026

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 172 Cr (Micro Cap)

stock-summary
P/E

35.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.34

stock-summary
Return on Equity

7.66%

stock-summary
Price to Book

2.67

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.94%
0%
-15.94%
6 Months
-28.57%
0%
-28.57%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Earkart for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Acquisition

30-May-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended and read with schedule III of aforesaid regulations dated 30 January 2026 the Board of Directors of the Company in their meeting held on 29 May 2026 has inter alia approved the incorporation of a wholly owned subsidiary by the name Earkart Pharmaceuticals Private Limited and Earkart Healthcare Services Private Limited.

Declaration Pursuant To Regulation 33(3)(D) Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended In Respect Of Audit Report With Unmodified Opinion For The Financial Year Ended 31 March 2026

29-May-2026 | Source : BSE

The statutory auditor of the Company M/s Timsi & Associates Chartered Accountants has issued Audit Report with unmodified opinion on the Audited Fiancial Results of the Company for the half yearly ended and yearly ended 31 March 2026.

Board Meeting Outcome for Outcome Of Board Meeting Dated 29 May 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015

29-May-2026 | Source : BSE

The Board of Directors of the Earkart Limited at its meeting held on 29 May 2026 inter alia considered and approved Audited Financial Results for the half year ended and financial year ended 31 March 2026 along with Independent Auditors Report issued by the statutory auditors M/s Timsi & Associates

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.80
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.72
Tax Ratio
31.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
21.95%
ROCE (avg)
26.47%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
35
Industry P/E
0
Price to Book Value
2.67
EV to EBIT
19.51
EV to EBITDA
17.97
EV to Capital Employed
3.52
EV to Sales
2.78
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.05%
ROE (Latest)
7.66%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Bearish
KST
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rohit Misra (55.04%)

Highest Public shareholder

Neomile Growth Fund- Series -i (16.92%)

Individual Investors Holdings

16.94%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Earkart"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 42.44% vs -5.35% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 66.49% vs -44.11% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.75",
          "val2": "22.29",
          "chgp": "42.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.21",
          "val2": "3.14",
          "chgp": "65.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.16",
          "val2": "0.39",
          "chgp": "-58.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.08",
          "val2": "1.85",
          "chgp": "66.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.41%",
          "val2": "14.09%",
          "chgp": "2.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Earkart"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 25.35% vs 35.78% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -28.34% vs 124.84% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "54.04",
          "val2": "43.11",
          "chgp": "25.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.36",
          "val2": "9.76",
          "chgp": "-14.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.54",
          "val2": "0.41",
          "chgp": "31.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.93",
          "val2": "6.88",
          "chgp": "-28.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.47%",
          "val2": "22.64%",
          "chgp": "-7.17%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
31.75
22.29
42.44%
Operating Profit (PBDIT) excl Other Income
5.21
3.14
65.92%
Interest
0.16
0.39
-58.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.08
1.85
66.49%
Operating Profit Margin (Excl OI)
16.41%
14.09%
2.32%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is 42.44% vs -5.35% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is 66.49% vs -44.11% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
54.04
43.11
25.35%
Operating Profit (PBDIT) excl Other Income
8.36
9.76
-14.34%
Interest
0.54
0.41
31.71%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.93
6.88
-28.34%
Operating Profit Margin (Excl OI)
15.47%
22.64%
-7.17%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 25.35% vs 35.78% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -28.34% vs 124.84% in Mar 2025

stock-summaryCompany CV
About Earkart Limited stock-summary
stock-summary
Earkart Limited
Micro Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available